13:45 – 14:00
Welcome words
Venkata Satagopam, head of the Clinical and Translational Informatics group, Luxembourg Centre for Systems Biomedicine
14:00 – 14:45
Keynote: Early disease risk prediction from longitudinal clinical records using AI
Chris Sander, Harvard Medical School
Session 1: Big data, AI and Machine Learning - current trends and future perspective
14:45 – 15:15
Deep Learning approaches for population scale trajectory modelling
Søren Brunak, University of Copenhagen
15:15 – 15:45
ELIXIR and European health data spaces: infrastructure for AI-Driven genomic medicine
Tim Hubbard, King’s College London & ELIXIR
15:45 – 16:15
Machine learning across the human proteome: predicting disease and drug response
Michal Linial, The Hebrew University of Jerusalem
16:30 – 17:00
Coffee break, industry exhibition and posters
16:15 – 16:30
2 Flash Talks (selected from abstracts)
Session 2: Target discovery and drug development
17:30 – 18:00
Translational chemical biology and AI-enabled target validation
Philip Gribbon, EU Openscreen
17:00 – 17:30
Protein structure space as a resource for drug discovery and repurposing
Christine Orengo, University College London
18:30 – 21:30
Networking dinner, industry exhibition and posters
18:00 – 18:30
Physics-informed machine learning for molecular and drug design
Alexandre Tkatchenko, University of Luxembourg
9:00 – 9:45
Keynote: Interpreting genetic variation with AI: from sequence to clinical relevance
Yana Bromberg, Emory University
Session 3: Computational models for precision medicine
9:45 – 10:15
AI-driven data integration for precision medicine at national scale
Alfonso Valencia, Barcelona Supercomputer Centre
10:15 – 10:45
Network-based clinical decision support using multi-omics data
Georgios Pavlopoulus, Biomedical Science Research Center “Alexander Fleming”
10:45 – 11:15
Coffee break, industry exhibition and posters
11:15 – 11:45
Machine learning models of tumour evolution for clinical decision support
Maria Secrier, University College London
Session 4: Technology and innovation - AI applications in pharma and medicine
11:45- 12:15
Building AI-enabled MedTech through public–private innovation partnerships
Christian Muehlendyck, Johnson&Johnson MedTech
12:15 – 12:30
2 Flash talks (selected from abstracts)
12:30 – 14:00
Lunch with industry exhibition and posters
14:00 – 14:15
TBC
14:15 – 14:45
From bioinformatics to individualised cancer therapy: lessons from Biotech innovation
Georg Casari, Co-Founder, Chief Executive Officer & Chief Operating Officer, YGION Biomedical Gmbh
14:45 – 15:15
Precision medicine partnerships: integrating genomics, AI and industry innovation
Matladi Ndlovu, Global Lead Innovative Precision Medicine Partnerships, UCB
15:15 – 15:45
4 Flash talks (selected from abstracts)
15:45 – 16:15
Coffee break, industry exhibition and posters
Session 5: Advances in bioinformatics: honouring the contributions of Prof. Reinhard Schneider
16:15 – 17:30
Various speakers – TBC
18:30 – onwards
Farewell dinner Reinhard Schneider